Reanalysis of publicly available cancer genomic data also suggested that of the four cancer histotypes that commonly exhibit pathogenic BRCA1/2 mutations, BRCA-mutant breast cancers tended to express higher POLQ mRNA than for BRCA-gene wild type breast cancers (Supplementary Fig. 1d). This evidence concerns the gene BRCA1 and breast cancer.